Announcement of Exhibition at “OPT Congress 2026”

 Mitsubishi Gas Chemical Company, Inc. (MGC; Head Office: Chiyoda-ku, Tokyo; President: Yoshinori Isahaya) will exhibit in OPT Congress 2026 (Oligonucleotide, mRNA & Peptide Therapeutics) held from March 18 to 19 in Boston, USA, which is one of the world’s leading international conferences in the fields of oligonucleotide, mRNA, and peptide drug discovery.

 OPT Congress brings together researchers involved in drug discovery, development, and manufacturing, as well as leaders in R&D and manufacturing fields and companies providing technologies and services that support drug discovery and manufacturing of oligonucleotide therapeutics and next-generation modalities. The conference marks its 11th year in 2026.

 At this conference, we will exhibit and introduce its oligonucleotide CRDMO (Contract Research, Development and Manufacturing Organization) services named as “AXELPHEX^TM.” In addition, we will present a poster on its purification technology currently under development for separating N-1 mer (single-base deletion impurities) generated during oligonucleotide manufacturing process.

END

[Reference]

■Exhibition Details:

          Event name:          OPT Congress 2026 (Oligonucleotide, mRNA & Peptide Therapeutics)
          Dates:                    March 18 - 19, 2026
          Location:                Boston, USA
          Venue:                   Seaport Hotel Boston
          Booth No.:             3
          Poster No.:            P06
          Website:                https://www.optcongress.com/

■ About AXELPHEX^TM

 "AXELPHEX^TM" is a jointly operated CRDMO platform by Mitsubishi Gas Chemical Company, Inc. and Hokkaido System Science Co., Ltd. for oligonucleotide APIs.
 Through an integrated framework that ensures stepwise optimization and seamless transition from research to GMP (Good Manufacturing Practice) manufacturing, AXELPHEX^TM combines efficiency with robust quality assurance. This platform provides flexible engagement from ad-hoc assignment on any process to fully integrated end‑to‑end project.
 For more details, please visit its website (https://axelphex.com/).